BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37468236)

  • 21. In deep bioinformatic characterization of a novel fumarate hydratase variant FH c.199T > G; (p.Tyr67Asp) in hereditary leiomyomatosis and renal cell carcinoma.
    Chami A; de Souza Zózimo TR; Alves TM; Matosinho CGR; Santos C; Simões MM; Cabral WLR; de Paula Ricardo BF; da Silva Filho AL; Carvalho MRS; da Conceição Braga L
    Fam Cancer; 2023 Oct; 22(4):481-486. PubMed ID: 37316640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of
    Liu L; Yang K; Wang X; Shi Z; Yang Y; Yuan Y; Guo T; Xiao X; Luo H
    Biomed Res Int; 2017; 2017():8751384. PubMed ID: 28785590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Expert consensus on the diagnosis and management of Birt-Hogg-Dubé syndrome].
    ; ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Sep; 46(9):897-908. PubMed ID: 37670643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal cell carcinoma in young FH mutation carriers: case series and review of the literature.
    Hol JA; Jongmans MCJ; Littooij AS; de Krijger RR; Kuiper RP; van Harssel JJT; Mensenkamp A; Simons M; Tytgat GAM; van den Heuvel-Eibrink MM; van Grotel M
    Fam Cancer; 2020 Jan; 19(1):55-63. PubMed ID: 31792767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fluorescent and chromogenic in situ hybridization of CEN17q as a potent useful diagnostic marker for Birt-Hogg-Dubé syndrome-associated chromophobe renal cell carcinomas.
    Kato I; Iribe Y; Nagashima Y; Kuroda N; Tanaka R; Nakatani Y; Hasumi H; Yao M; Furuya M
    Hum Pathol; 2016 Jun; 52():74-82. PubMed ID: 26980015
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal cell tumour characteristics in patients with the Birt-Hogg-Dubé cancer susceptibility syndrome: a retrospective, multicentre study.
    Benusiglio PR; Giraud S; Deveaux S; Méjean A; Correas JM; Joly D; Timsit MO; Ferlicot S; Verkarre V; Abadie C; Chauveau D; Leroux D; Avril MF; Cordier JF; Richard S;
    Orphanet J Rare Dis; 2014 Oct; 9():163. PubMed ID: 25519458
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Birt-Hogg-Dubé Syndrome and Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome: An Effective Multidisciplinary Approach to Hereditary Renal Cancer Predisposing Syndromes.
    Al-Shinnag M; Marfan H; Susman R; Wakeling J; Gustafson S; Wood S; Mallett AJ
    Front Oncol; 2021; 11():738822. PubMed ID: 34604083
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel germline mutations in FLCN gene identified in two Chinese patients with Birt-Hogg-Dubé syndrome.
    Li T; Ning X; He Q; Gong K
    Chin J Cancer; 2017 Jan; 36(1):4. PubMed ID: 28069055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer.
    Wei MH; Toure O; Glenn GM; Pithukpakorn M; Neckers L; Stolle C; Choyke P; Grubb R; Middelton L; Turner ML; Walther MM; Merino MJ; Zbar B; Linehan WM; Toro JR
    J Med Genet; 2006 Jan; 43(1):18-27. PubMed ID: 15937070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complete Penetrance and Absence of Intrafamilial Variability in a Large Family with Hereditary Leiomyomatosis and Renal Cell Carcinoma.
    Guinard E; Legendre L; Kramkimel N; Avril MF; Chassaing N; Cabaret O; Guillaud-Bataille M; Mazereeuw Hautier J
    Dermatology; 2016; 232(3):293-7. PubMed ID: 27161211
    [TBL] [Abstract][Full Text] [Related]  

  • 31. No evidence for a genetic modifier for renal cell cancer risk in HLRCC syndrome.
    Vahteristo P; Koski TA; Näätsaari L; Kiuru M; Karhu A; Herva R; Sallinen SL; Vierimaa O; Björck E; Richard S; Gardie B; Bessis D; Van Glabeke E; Blanco I; Houlston R; Senter L; Hietala M; Aittomäki K; Aaltonen LA; Launonen V; Lehtonen R
    Fam Cancer; 2010 Jun; 9(2):245-51. PubMed ID: 20091131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Birt-Hogg-Dubé syndrome in Korean: clinicoradiologic features and long term follow-up.
    Lee JH; Jeon MJ; Song JS; Chae EJ; Choi JH; Kim GH; Song JW
    Korean J Intern Med; 2019 Jul; 34(4):830-840. PubMed ID: 30360018
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Update of penetrance estimates in Birt-Hogg-Dubé syndrome.
    Bruinsma FJ; Dowty JG; Win AK; Goddard LC; Agrawal P; Attina' D; Bissada N; De Luise M; Eisen DB; Furuya M; Gasparre G; Genuardi M; Gerdes AM; Hansen TVO; Houweling AC; Johannesma PC; Lencastre A; Lim D; Lindor NM; Luzzi V; Lynch M; Maffé A; Menko FH; Michels G; Pulido JS; Ryu JH; Sattler EC; Steinlein OK; Tomassetti S; Tucker K; Turchetti D; van de Beek I; van Riel L; van Steensel M; Zenone T; Zompatori M; Walsh J; Bondavalli D; Maher ER; Winship IM;
    J Med Genet; 2023 Apr; 60(4):317-326. PubMed ID: 36849229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A case of Birt-Hogg-Dubé syndrome implying reduced or no wild-type folliculin without mutated protein is pathogenic.
    Enomoto Y; Namba Y; Hoshika Y; Komemushi Y; Mitani K; Kume H; Kobayashi E; Miyama Y; Homma Y; Ushiku T; Seyama K
    Eur J Med Genet; 2020 Apr; 63(4):103820. PubMed ID: 31778855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Birt-Hogg-Dubé syndrome in two Chinese families with mutations in the FLCN gene.
    Hou X; Zhou Y; Peng Y; Qiu R; Xia K; Tang B; Zhuang W; Jiang H
    BMC Med Genet; 2018 Jan; 19(1):14. PubMed ID: 29357828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hereditary renal cell carcinoma syndromes: diagnosis, surveillance and management.
    Maher ER
    World J Urol; 2018 Dec; 36(12):1891-1898. PubMed ID: 29680948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PRDM10 directs FLCN expression in a novel disorder overlapping with Birt-Hogg-Dubé syndrome and familial lipomatosis.
    van de Beek I; Glykofridis IE; Oosterwijk JC; van den Akker PC; Diercks GFH; Bolling MC; Waisfisz Q; Mensenkamp AR; Balk JA; Zwart R; Postma AV; Meijers-Heijboer HEJ; van Moorselaar RJA; Wolthuis RMF; Houweling AC
    Hum Mol Genet; 2023 Mar; 32(7):1223-1235. PubMed ID: 36440963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cryptic splice mutation in the fumarate hydratase gene in patients with clinical manifestations of Hereditary Leiomyomatosis and Renal Cell Cancer.
    Crooks DR; Cawthon GM; Fitzsimmons CM; Perez M; Ricketts CJ; Vocke CD; Yang Y; Middelton L; Nielsen D; Schmidt LS; Tandon M; Merino MJ; Ball MW; Meier JL; Batista PJ; Linehan WM
    Hum Mol Genet; 2023 Nov; 32(22):3135-3145. PubMed ID: 37561409
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early onset renal cell carcinoma in an adolescent girl with germline FLCN exon 5 deletion.
    Schneider M; Dinkelborg K; Xiao X; Chan-Smutko G; Hruska K; Huang D; Sagar P; Harisinghani M; Iliopoulos O
    Fam Cancer; 2018 Jan; 17(1):135-139. PubMed ID: 28623476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathology of Birt-Hogg-Dubé syndrome: A special reference of pulmonary manifestations in a Japanese population with a comprehensive analysis and review.
    Furuya M; Nakatani Y
    Pathol Int; 2019 Jan; 69(1):1-12. PubMed ID: 30632664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.